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Abstract
Background/Aims: Hypoxia is a powerful stimulator of angiogenesis under physiological as 
well as pathological conditions. Normal endothelial cells (EC), such as human umbilical vein EC 
(HUVEC), are relatively affected by hypoxic insult in terms of cell survival. In contrast, EC from 
tumors are particularly resistant to hypoxia-induced cell death. Previous reports have shown 
that EC in bone marrow from multiple myeloma (MM) patients had a hypoxic phenotype, even 
under normoxic conditions. The aim of this study was to evaluate whether HUVEC and MMEC 
adapt differently to hypoxia. Methods: Cell proliferation was assessed by the CyQUANT assay. 
Cdc25A, p21, Bax, Bcl-xl, BNIP3, glucose transporter (GLUT)-1, monocarboxylate transporter 
(MCT)-4 and carbonic anhydrase (CA)IX mRNA expression was determined by qRT-PCR. HIF-1α, 
BNIP3, Beclin-1, LC3B, livin, Bax, Bcl-xl, p21, p62 and β-actin protein expression was analyzed by 
western blot. Apoptosis was determined by TUNEL assay. Silencing of BNIP3 was achieved by 
stealth RNA system technology. Results: While HUVEC survival was reduced after prolonged 
hypoxic exposure, MMEC were completely unaffected. This difference was also significant in 
terms of livin, cdc25A and p21 expression. Hypoxia induced apoptosis and inhibited autophagy 
in HUVEC, but not in MMEC, where hypoxic treatment resulted in a more sustained adaptive 
response. In fact, MMEC showed a more significant increase in the expression of genes 
regulated transcriptionally by hypoxia-inducible factor (HIF)-1α. Interestingly, they showed 
higher expression of BNIP3 than did HUVEC, indicating a more pronounced autophagic (and 
pro-survival) phenotype. The potential role of BNIP3 in EC survival was confirmed by BNIP3 
siRNA experiments in HUVEC, where BNIP3 inhibition resulted in reduced cell survival and 
increased apoptosis. Conclusion: These findings provide further information on how hypoxia 
may affect EC survival and could be important for a better understanding of EC physiology 
under normal and pathological conditions, such as in multiple myeloma.
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IntroductionHypoxia is a common feature in various physiological and pathological conditions [1]. Different types of cells may adapt differently to hypoxia by modulating gene expression through the transcription factor hypoxia-inducible factor (HIF)-1 to overcome oxygen 
shortage [2]. HIF-1 is an αβ-heterodimer and HIF-α and HIF-β subunits exist as a series 
of isoforms encoded by distinct genetic loci [3]. HIF-1β can dimerize with different basic 
helix-loop-helix-PAS proteins and is constitutive, while HIF-α subunits are induced by 
hypoxia. Of the three HIF-α isoforms, HIF-1α is the primary source of hypoxic transcriptional 
response [4, 5], which involves interacting with hypoxia response elements (HREs) to induce transcriptional activity [6].
The role of the HIF pathway in cell death is controversial; HIF-1 can induce apoptosis and 
autophagy, prevent cell death, or even stimulate cell proliferation. Indeed, HIF-1α activates 
transcription of genes encoding Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3), 
which triggers selective autophagy [7]. Interdependence between autophagy and apoptosis 
seems to depend on cell type and the cellular environment. However, it has been clearly demonstrated that autophagy is a basic mechanism for maintaining cellular homeostasis, as 
well as a survival strategy [8, 9].
With regard to cell death, endothelial cells (EC) are less susceptible than other cell types to hypoxic stress [10]. They tend to adapt better to hypoxia in terms of cell survival [11]. 
Furthermore, EC of tumor vessels differ greatly from those of quiescent healthy vessels [12]: 
they proliferate rapidly, in keeping with the enhanced angiogenesis associated with tumor 
progression (growth, invasion and metastasis). Their survival not only depends on the 
growth factors (and their receptors) in the tumor microenvironment, but also on hypoxia [13].
Previous reports have shown that bone marrow angiogenesis is a constant hallmark of 
progression of multiple myeloma (MM) [14]. Indeed, MM endothelial cells (MMEC) play a 
crucial role in MM progression and HIF-1α protein is reported to be expressed constitutively 
and activated in MMEC in a well-deﬁned proportion of patients experiencing relapse or 
refractory to treatment. More importantly, patients with MMEC expressing the HIF-1α protein have shorter overall survival [15].
Although the pro-angiogenic role of HIF-1α has already been established in MM [15, 
16], to our knowledge no studies have documented MMEC adaptive response to hypoxia in terms of survival, apoptosis and/or autophagy. We therefore decided to investigate and 
compare the effects of hypoxia on bone marrow EC of active multiple myeloma patients and 
on healthy quiescent EC, namely human umbilical vein EC (HUVEC).
Materials and Methods
Cell culture and hypoxic treatment
HUVEC and appropriate growth medium were purchased from Lonza (Walkersville, MD, USA) 
and cultured with 10% FBS, as indicated by the manufacturer. Bone marrow primary multiple myeloma 
endothelial cells (MMEC) were obtained as previously described [14] and cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Euroclone, Devon, UK) supplemented with 20% FBS. The experiments, conducted 
under aerobic conditions, were performed using an incubator (VWR International PBI, Milano, Italy) 
set at 5% CO2, 20% O2 (atmospheric oxygen ≈ 140 mmHg) and 37°C in a humidified environment. The 
experiments under hypoxic conditions were performed using a workstation InVivo 400 (Ruskinn, Pencoed, 
UK) which provides a stable customized humidified environment through electronic control of CO2 (5%), O2 
and temperature (37°C). In our experiments, O2 was set and maintained constantly at 2% (≈ 14 mmHg) by 
injecting N2 automatically into the chamber, as previously described [17]. Cells were plated and allowed to 
adhere overnight. The next morning they were incubated in normoxia or hypoxia for the indicated times. At 
the end of the experiments, the cells were analyzed as follows.
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Cell proliferation assay
Cell proliferation was assessed with the CyQUANT Kit (Molecular Probe, Eugene, OR, USA), according 
to the manufacturer’s instructions, as previously described [18]. Cells (2x104 cells/ml) were exposed to 
normoxia or hypoxia for 8-24-48 h. Fluorescence was measured using a microplate reader (FluostarOptima, 
BMG LABTECH, Durham, NC, USA).
RNA preparation and real-time PCR
Cdc25A, p21(p21/WAF1), Bax, Bcl-xl, BNIP3, glucose transporter (GLUT)-1, monocarboxylate 
transporter (MCT)-4 and carbonic anhydrase (CA)IX mRNA expression was determined by real-time PCR 
using an iQTM5 Multicolor Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) as 
previously described [17]. Briefly, total RNA was extracted from normoxic or hypoxic cells using the TRI 
Reagent® (Ambion, Austin, TX, USA). First-strand cDNA was synthesized using an iScriptTMcDNA Synthesis Kit 
(Bio-Rad Laboratories). qRT-PCR was performed using iTaqTMSYBR Green Supermix (Bio-Rad Laboratories) 
and the specific primers were designed by the Primer-BLAST program (available at https://blast.ncbi.nlm.
nih.gov). Thermocycler conditions included an initial hold at 95°C for 30 sec, followed by a two-step PCR 
program: 95°C for 10 sec and 60°C for 30 sec for 49 cycles. CAIX mRNA expression was determined by 
TaqMan-Based Multiplex real-time PCR. p21 (p21/WAF1), Bax, Bcl-xl, BNIP3, GLUT-1 and MCT-4 primers 
were purchased from Invitrogen (Paysley, UK), while Cdc25A and CAIX primers and TaqMan probes were 
obtained from Eurofins Genomics (Ebersberg, Germany). Data were analyzed quantitatively with iQTM5 
Optical System Software (Bio-Rad Laboratories). Relative quantification was done using the 2-ΔΔCT method 
[19] and β-actin was used as housekeeping control. The specificity of PCR amplification of each primer pair 
was confirmed analyzing PCR products by agarose gel electrophoresis and melting curve analysis.
Western blot analysis
For western blot analysis, cells were promptly processed to avoid culture reoxygenation, appropriately 
lysed and analyzed using antibodies against HIF-1α (BD Biosciences, San Jose, CA), BNIP3 (Thermo Scientific, 
Rockford, IL, USA), Beclin-1, LC3B, p62, Bax, Bcl-xl and β-actin (Cell Signaling, Danvers, MA, USA) and p21 
(p21/WAF1; Oncogene Research Products, San Diego, CA). Chemiluminescence was detected and quantified 
using a ChemiDoc XRS apparatus and Quantity One software (Bio-Rad Laboratories) as previously described 
[17].
Human apoptosis array
Analysis of livin protein expression was performed with a Human Apoptosis Array kit (R&D Systems, 
Minneapolis, MN, USA). Both normoxic and hypoxic cells were lysed in the appropriate buffer at 2–8°C for 
30 min and processed according to the manufacturer’s instructions. Chemiluminescence was detected by 
ChemiDoc XRS/Quantity One software (Bio-Rad Laboratories) and quantitative evaluation was based on 
pixel densities, which were calculated and normalized to reference spots, as indicated by the manufacturer.
TUNEL Assay
Apoptosis was determined on cells exposed to normoxia or hypoxia for 48 h. A terminal deoxynucleotidyl 
transferase dUTP nick-end labeling (TUNEL) assay was conducted using an HT Titer-TACS™ assay kit 
(Trevigen, Gaithersburg, MD, USA) according to the manufacturer’s protocol. TUNEL-positive cells were 
measured at absorbance 450 nm using a Multiskan EX 96-well plate reader (Thermo Scientific, Rockford, IL, 
USA) after addition of 0.2 N HCl. As positive control, cells were treated with TACS-nuclease, supplied with 
the assay kit, for 1 h at 37°C before hydrogen peroxide treatment.
BNIP3 siRNA
Silencing of BNIP3 was achieved by stealth RNA system technology (Invitrogen). The siRNA target 
sequences are Exon 2 (NM_004052) of human BNIP3 mRNA; negative controls were designed with the same 
CG ratio without any known human genome target. HUVEC were transfected in suspension using Neon™ 
Transfection System (Invitrogen) according to the manufacturer’s instructions and incubated for 24 h with 
stealth RNA at a concentration of 50 nM. Following transfection, cells were exposed to normoxia or hypoxia 
for 48 h. Real-time PCR, western blot analysis, cell proliferation and apoptosis were conducted as described above.
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Statistical analysis
Statistical significance between means was determined using Student’s t test. A value of p < 0.05 was 
considered statistically significant.
Results
Hypoxia affects HUVEC and MMEC proliferation differently
Although HUVEC proliferation was relatively affected by hypoxia, MMEC were 
completely resistant. The HUVEC viability assay revealed an apparent reduction in cell proliferation after 24 h of continuous exposure to an oxygen partial pressure of 14 mmHg (Fig. 1a). The reduction became 
statistically significant after 48 h of hypoxic treatment. In contrast, 
MMEC proliferation was not affected 
by 24 h of hypoxia, or even 48 h of 
continuous exposure. HUVEC and 
MMEC proliferation patterns under 
hypoxia were evaluated by several 
techniques. The human apoptosis 
array kit revealed significant enhancement of expression of the protein livin (an apoptosis inhibitor) 
in MMEC exposed to hypoxia for 48 
h, in contrast with HUVEC (Fig. 1b). We also determined the expression of cdc25A, a member of the cdc25 
family of phosphatases, which is 
required for progression from G1 to 
the S phase of the cell cycle. As shown 
in Fig. 1c, cdc25A mRNA expression 
was significantly enhanced in 
hypoxic MMEC, and significantly 
reduced in HUVEC. In contrast, 
mRNA and protein expression of the 
cyclin-dependent kinase inhibitor 
1, p21, was significantly enhanced 
in HUVEC and reduced in MMEC, 
confirming resistance of MMEC to hypoxic insult (Fig. 1d).
MMEC are more resistant to 
hypoxia-induced cell death than 
HUVEC
Since HUVEC and MMEC 
viabilities were differently affected 
by hypoxia, we decided to evaluate 
the mechanism involved. Cell 
death was analyzed by different 
approaches to determine whether it 
was related to apoptosis.
To detect cell apoptosis, DNA 
fragmentation was evaluated by 
Fig. 1. HUVEC and MMEC proliferation under hypoxia. (a) 
Cells were exposed to hypoxia for 8-24-48 h and cell prolif-
eration was expressed as a percentage with respect to con-
trols at 8 h. (b) Livin protein expression was determined by 
a human apoptosis array kit after 48 h of hypoxia. (c) cdc25A 
mRNA expression was determined by real-time PCR after 48 
h of hypoxic treatment. (d) p21 mRNA and protein expres-
sion were assessed at 48 h by real-time PCR and western 
blot analysis using β-actin as protein loading control. Repre-sentative blots from three independent experiments for livin 
and p21 are shown. Densitometric quantification of protein 
expression was achieved by chemiluminescence and is ex-pressed in relation to normoxic controls. Data are means ± 
SEM of three separate experiments. *p<0.05, hypoxia versus normoxia.
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TUNEL assay on HUVEC and MMEC 
exposed to hypoxia. In HUVEC, 48 
h exposure induced a significant increase in the percentage of 
apoptotic cells, whereas MMEC were unaffected (Fig. 2a). Since the ratio of Bax to Bcl-xl expression is an 
index of apoptosis, we calculated it 
at mRNA and protein levels by real-
time PCR and western blot analysis. 
With the TUNEL assay results, 48 h exposure to hypoxia enhanced 
the Bax/Bcl-xl ratio at mRNA and 
protein levels in HUVEC, whereas it 
was significantly reduced in MMEC 
(Fig. 2b). This indicates that HUVEC are more prone to apoptosis than 
MMEC under hypoxia. Finally, we 
decided to investigate whether hypoxia affects expression of pro-
autophagic markers, such as Beclin-1 
and LC3B-I and –II, in different 
ways (Fig. 2c). Interestingly, 48 h exposure to hypoxia resulted in a 
significant reduction in Beclin-1 
expression in HUVEC. We also observed a similar reduction in the 
LC3B-II/ LC3B-I ratio, indicating an impaired autophagic process. In contrast, hypoxia did not affect expression of these autophagic 
markers in MMEC. For a better 
characterization of autophagy, we also evaluated expression of p62, 
a protein whose degradation is 
normally associated with autophagic 
flux [20]. In our experiments, p62 
expression was only significantly 
reduced in hypoxic MMEC and not in 
HUVEC (Fig. 2d). The overall results 
indicate that HUVEC are more prone to apoptosis and less predisposed to 
autophagy than MMEC, supporting 
the hypothesis that MMEC are more resistant to hypoxia-induced cell 
death than HUVEC.
Hypoxia-induced responses are more evident in MMEC than in HUVEC
Hypoxia seems to affect MMEC and HUVEC proliferative and apoptotic profiles differently. 
To determine whether these observations were associated with different adaptive responses 
to hypoxia we evaluated the hypoxic signature in both cell types. Previous reports have 
shown that MMEC express higher protein levels of HIF-1α than do HUVEC under normoxic 
conditions [15]. As shown in Fig. 3a, expression of HIF-1α was significantly higher in MMEC 
than in HUVEC under hypoxia. We then analyzed the gene expression profile associated 
Fig. 2. Hypoxia-induced cell death in MMEC and HUVEC. (a) 
Apoptosis was determined by TUNEL assay on cells exposed 
to hypoxia for 48 h. Data are expressed as percentages with 
respect to normoxic controls. (b) Bax and Bcl-xl mRNA and 
protein expression, assessed by real-time PCR and western blot analysis, are reported as Bax/Bcl-xl ratio. (c) Protein ex-
pression of Beclin-1, LC3B-I and LC3B-II, (d) p62 was evalu-
ated by western blot analysis using β-actin as protein load-ing control. A representative blot from three independent 
experiments is shown. Densitometric quantification of pro-
tein expression was achieved by chemiluminescence and is expressed in relation to normoxic controls for Bax/Bcl-xl, Be-
clin and LC3B-II/LC3B-I, as well as for p62. Data are means 
± SEM from at least three independent experiments. *p<0.05, hypoxia versus normoxia.
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with a hypoxic signature. We 
determined expression of CAIX, 
GLUT-1 and MCT-4, as they are all transcriptionally regulated by HIF-
1α. qRT-PCR results clearly 
showed that under hypoxia, 
CAIX, GLUT-1 and MCT-4 mRNA 
levels were significantly higher than in normoxic controls and 
more evident in MMEC than in 
HUVEC (Fig. 3b-d).
Among genes uniquely 
regulated by HIF-1α at 
transcriptional level, BNIP3 is involved in a program exploited by several cell types to survive hypoxic insult [21]. 
Like HIF-1α, BNIP3 is highly 
expressed in MMEC under normoxic conditions [22]. As 
shown in Fig. 4a, BNIP3 was expressed more in MMEC than 
in HUVEC at mRNA and protein levels. To further analyze this 
observation, we performed kinetic experiments that showed 
an evident difference in BNIP3 expression profile in the two 
cell types (Fig. 4b). As expected, mRNA levels of BNIP3 were 
always higher under hypoxic conditions in both cell types. 
In HUVEC, exposure to hypoxia caused a modest increase 
in BNIP3 expression, which was enhanced at 8 h and then 
declined at 24 h and 48 h. In contrast, in MMEC we observed 
an initial sharp increase in BNIP3 mRNA expression at 8 h 
which was further increased at 24h and 48 h. These results 
clearly indicate that MMEC tend to adapt to hypoxia more 
efficiently than HUVEC and that BNIP3 expression may play a role in cell survival.
Fig. 3. Hypoxic signatures in MMEC 
and HUVEC. (a) HIF-1α protein expres-
sion after 8 h of hypoxia was evaluated 
by western blot analysis using β-actin as protein loading control. A repre-sentative blot from three independent 
experiments is shown. Densitometric 
quantification was achieved by che-
miluminescence and expressed with 
respect to hypoxic HUVEC as control. * 
p<0.05, significantly different from HU-
VEC (n = 3). (b) CAIX, (c) GLUT-1 and (d) 
MCT-4 mRNA expression was defined 
by real-time PCR after 24 h of hypoxic 
incubation. Data are means ± SEM from three to four independent experiments. 
*p<0.05, hypoxia versus normoxia.
Fig. 4. BNIP3 expression in 
MMEC and HUVEC under hy-
poxia. (a) BNIP3 mRNA and pro-
tein expression were defined by 
real-time PCR and Western blot 
in MMEC and HUVEC and com-
pared at zero time. * p<0.05, sig-
nificantly different from HUVEC 
(n = 3). (b) Kinetics of BNIP3 
mRNA expression, as defined by 
real-time PCR. * p<0.05, signifi-cantly different from normoxia.
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Inhibition of BNIP3 
reduces HUVEC survival 
under hypoxiaPrevious reports established a role of 
BNIP3 in adaptation to hypoxia by several cell types [21]. It has also been reported that ablation of 
BNIP3 in cells where it is 
overexpressed (e.g. MMEC) promoted apoptosis [22]. To better establish the role 
of BNIP3 in EC survival under hypoxic conditions, 
we evaluated proliferation and apoptosis/autophagy 
in HUVEC in which BNIP3 
was inhibited by siRNA 
technology. As shown in 
Fig. 5a, inhibition of BNIP3 
resulted in a significant 
reduction of BNIP3 
expression at mRNA (more 
than 90%) and protein levels, under normoxic and hypoxic conditions. 
Inhibition was associated 
with a reduction in cell proliferation (Fig. 5b) and enhancement of apoptosis 
(Fig. 5c). In contrast with the results obtained in hypoxic 
MMEC, where BNIP3 was 
overexpressed, BNIP3 
inhibition in hypoxic HUVEC resulted in a reduction in the autophagic process. 
Indeed, the LC3B-II/LC3B-I 
ratio was significantly lower 
in hypoxic HUVEC, where 
BNIP3 was silenced, than in hypoxic controls (Fig. 5d). Again our results indicate 
a crucial role of BNIP3 not only in the survival of pathological and highly 
proliferative EC (i.e. MMEC) 
but also of normal quiescent 
EC (i.e. HUVEC) in a hypoxic microenvironment.
Fig. 5. Inhibition of BNIP3 by siRNA in HUVEC under hypoxia. HU-
VEC transfected with scrambled (Ctr siRNA) or BNIP3 siRNA were 
exposed to hypoxia for 48 h. (a) BNIP3 mRNA and protein expression 
were determined by real-time PCR and western blot analysis. A rep-
resentative blot from three independent experiments is shown. Den-
sitometric quantification was performed by chemiluminescence. Data 
are presented as BNIP3 siRNA versus the corresponding Ctr siRNA. ** 
p<0.05, statistically significant difference between BNIP3 siRNA and 
control siRNA (Ctr siRNA). (b) Cell proliferation and (c) apoptosis were 
expressed as percentages with respect to normoxic controls. * p<0.05, 
significantly different from normoxia. ** p<0.05, statistically significant 
difference between BNIP3 siRNA and control siRNA (Ctr siRNA). (d) 
LC3B-I and LC3B-II protein expression was evaluated by western blot analysis and a representative blot from three independent experiments 
is shown. Quantification data is reported as LC3B-II/LC3B-I ratio in re-
lation to normoxic Ctr siRNA. ** p<0.05, statistically significant differ-
ence between BNIP3 siRNA and control siRNA (Ctr siRNA).
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Discussion
Several reports have indicated that EC are particularly resistant to hypoxic stress. 
Compared to other primary cell lines, including neurons and cardiomyocytes, EC only die 
after prolonged exposure to hypoxia [10]. Previous studies show that EC from tumor vessels 
are functionally different from quiescent EC, in line with the increased angiogenesis involved in tumor progression [23, 24]. We sought to compare the adaptive responses to hypoxia of 
EC from healthy quiescent vessels (HUVEC) and from tumor vessels (MMEC). This is the first 
report that MMEC are more resistant than HUVEC to hypoxic stress in terms of cell viability, 
being more prone to autophagy and less predisposed to apoptosis. The fact that MMEC were 
less prone to apoptosis was clarified by previous studies, which, however, were conducted 
under normoxic conditions [22]. In our study, we determined that HUVEC were less resistant 
than MMEC to cell death due to prolonged exposure to hypoxia. Indeed, short exposure 
to hypoxia failed to induce cell death in either cell type. This is consistent with previous 
observations showing that HUVEC are resistant to hypoxia-induced cell death after 24 h 
of exposure [10]. However, while HUVEC were less viable after 48 h of hypoxic treatment, 
MMEC continued to resist. Compared with HUVEC, MMEC expressed a higher level of livin 
and cdc25A and a lower level of p21. This is in line with previous reports indicating that 
downregulation of cdc25 and upregulation of p21 expression in EC correlates with cell cycle arrest [25, 26]. With regard to livin, an inhibitor of apoptosis proteins, our observations 
show that its expression is positively correlated with cell survival [27]. Our results are 
also in agreement with previous reports indicating that hypoxia-induced death of HUVEC 
could be attributed to apoptosis [10]. However, the latter authors did not find any apparent 
correlation with alterations in Bax and Bcl-xl proteins. In our hands, such alterations were 
only relatively significant after 48 h of hypoxia. More interestingly, in hypoxic MMEC, Bax/
Bcl-xl expression was significantly reduced, in line with the hypothesis that MMEC are more 
resistant to hypoxia-induced cell death. It is important to underline the significant reduction 
in Beclin-1 expression and in the LC3B-II/LC3B-I ratio in hypoxic HUVEC. Beclin-1 is a 
major agent and initiator of autophagy [7] and when autophagy is activated, cytoplasmic 
LC3B-I protein is cleaved, lipidated and inserted into autophagosome membranes as LC3-
II [28]. Thus an increase in the amount of the smaller molecular weight LC3-II protein and 
an increase in the LC3-II/LC3-I ratio are a hallmark of autophagy and correlated with an 
increased number of autophagosomes. Autophagy is also associated with p62 degradation 
[20] and indeed here we found that hypoxic MMEC expressed lower p62 levels. As previously 
shown, autophagy may be considered a pro-survival adaptive response in several cell types 
[8, 21, 29]. This may further explain why HUVEC are less resistant to hypoxia-induced cell 
death than MMEC, which in comparison appeared to be more prone to autophagy.
Previous reports clearly illustrate how cells adapt to hypoxia by expression of genes 
closely regulated by HIF-1α, including CAIX, GLUT-1, MCT-4 and BNIP3, in order to survive 
in a hostile microenvironment [30-33]. The fact that HUVEC tended to accumulate less 
HIF-1α than MMEC, and that MMEC expressed higher mRNA levels of CAIX, GLUT-1, MCT-4 
and BNIP3 than HUVEC, supports the hypothesis that MMEC show a better metabolic and 
autophagic adaptive response to hypoxic stress. Indeed, BNIP3 has been described as a key 
molecule induced by hypoxia and involved in the autophagic switch enabling cells to survive 
and to avoid apoptosis [21]. Our results fully agree with previous reports demonstrating 
that hypoxia-induced autophagy is a survival process and is linked to the expression of 
BNIP3 and BNIP3like (BNIP3L) [7]. The same authors report that ectopic expression of 
BNIP3 and BNIP3L triggers autophagy under normoxic conditions. It should be underlined 
that MMEC overexpress BNIP3 even under normoxia [22] and our results clearly define its 
overexpression in MMEC under hypoxic conditions. The proposed protective role of BNIP3 
in EC exposed to hypoxia is further corroborated by the fact that when BNIP3 was silenced in 
HUVEC, we observed lower viability and increased apoptosis. This is in line with a previous 
study showing that increased apoptosis occurs when BNIP3 is inhibited in MMEC [22]. In 
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conclusion, our results suggest that understanding the mechanisms by which different EC adapt to hypoxia may have important therapeutic implications.
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